This medical education webinar, hosted by EMG-Health on 17th November 2020, sought to educate the virtual audience on therapeutic drug monitoring (TDM) in inflammatory bowel disease (IBD), and on how TDM can be used with treat-to-target (T2T) to improve clinical outcomes.
EMJ Gastroenterology 10 [Supplement 1] . 2021
February 2021
In this issue
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.
Thank you!
Please share some more information on the rating you have given